End-stage renal failure
Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia.
2
en fr End-stage renal disease and cardiovascular disease : the burden of chronic disease in French Guiana. Insuffisance rénale terminale et maladies cardiovasculaires : le poids des maladies chroniques en Guyane
225
Reversal of Acute Renal Failure by Kidney Revascularisation
6
A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease.
14
Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the epiran community-based study
14
View of Acute renal failure: epidemiology, treatment
5
Muscle wasting in patients with end‐stage renal disease or early‐stage lung cancer: common mechanisms at work
16
Hemodialysis management strategies for migrant patients with end-stage chronic renal disease
60
View of Acute Renal Failure: Accuracy of a Classification Based on Time to Recovery
6
Plasma cystatin C for the detection of renal failure in obese patients
1
View of Acute renal failure during intensive care — Long-term prognosis
6
View of Acute renal failure during intensive care — Prevention and treatment
8
View of Acute renal failure during intensive care — Mechanisms and diagnosis
6
Systematic Analysis of Blood Cell Transcriptome in End-Stage Chronic Respiratory Diseases
15
Mechanical Circulatory Support for End-Stage Heart Failure
18
Renal failure and occupational exposure to organic solvents: what work-up should be performed?
4
Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays
35
Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease
16
View of Involvement of innate immunity beyond response to infection — Innate immunity and acute renal failure
5
ACE I/D polymorphism predicts end stage renal disease and or mortality in type I diabetic patients except for those with already advanced nephropathy: the follow up of the Genesis/Genediab Studies
1